The company reported a 13.5% increase in gross profit and a 16.6% rise in adjusted EBITDA for the quarter.
Grey Wolf Animal Health posted Q1 revenue of C$8.8 million, up 11.4% year-over-year. The increase reflects stronger demand in its core markets, driving growth across key segments.
Gross profit climbed 13.5% to C$4.7 million, while adjusted EBITDA rose 16.6% to C$1.5 million. Cash and cash equivalents reached C$8.8 million at March 31, 2026, compared to C$7.7 million at December 31, 2025.
The results highlight improved operational efficiency and higher margins amid steady revenue expansion.